USA's economic downturn resulting in Pharma becoming target for organized crime

23 November 2010

According to data from FreightWatch, a USA-based freight security consultancy, rising demand in the USA for expensive medicines since the economic downturn has helped make pharmaceutical shipments a growing target for organized criminal gangs.

The data show that at least 41 robberies of prescription drugs from trucks and warehouses have taken place so far this year, with an average value of nearly $5 million. In 2009, 47 incidents worth $4 million each were recorded.

Commenting on the FreightWatch findings, the UK’s Financial Times notes that drugs have become a preferred product to steal, given the difficulty of tracking criminals, low penalties and the high value of hauls often sold on-line to patients unwilling to seek a doctor’s appointment or without health insurance to pay for their drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical